Concepedia

Sarah L. Opitz

SL

4

Publications

984

Citations

4

H-Index

2002

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Sarah L. Opitz is an author at Harvard University specializing in cancer research, drug resistance, and drug discovery.

Top concepts

Publications per year

2002–2004

4

Publications

4

LIF/STAT3 Signaling Fails to Maintain Self‐Renewal of Human Embryonic Stem Cells

Laurence Dahéron, Sarah L. Opitz, Holm Zaehres et al. · Stem Cells · 2004 · 459 citations · Full text

The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling

Margit Hagel, Elizabeth George, Ann Kim et al. · Molecular and Cellular Biology · 2002 · 326 citations · Full text

Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis

Michelle H. Tan, Zhengwu Sun, Sarah L. Opitz et al. · Blood · 2004 · 177 citations · Full text

A screen to identify drug resistant variants to target-directed anti-cancer agents

Mohammad Azam, Tal Raz, Valentina Nardi et al. · Biological Procedures Online · 2003 · 22 citations · Full text

, , +10

Rows per page

1–4 of 4